How to Get Discounts on Vascepa
Vascepa (icosapent ethyl) has a list price around $300-$400 per month without insurance, but patient assistance programs cut costs significantly. Amarin Pharma, the manufacturer, offers a Vascepa Savings Card for commercially insured patients, reducing copays to $0 for up to 13 fills (about a year) if eligible—check eligibility at vascepa.com/savings.[1] Uninsured patients may qualify for the Amarin CAREs program, providing free medication based on income (typically under 400% of federal poverty level).[1]
Who Qualifies for Free or Low-Cost Vascepa?
Eligibility varies:
- Savings Card: Commercial insurance, no government plans like Medicare/Medicaid. Covers up to $15,000 annually in copay assistance.
- Amarin CAREs: Income-based for uninsured/underinsured; apply online or call 1-877-304-3189.
- Medicare patients: Limited options since manufacturer copay cards are restricted, but GoodRx or SingleCare can drop prices to $250-$300 per month.[2][3]
Cheapest Ways to Pay with Coupons
Use these for instant discounts at pharmacies:
| Service | Typical Discount | How to Use |
|---------|------------------|------------|
| GoodRx | $250-$290 for 120 capsules | Print coupon or app; no sign-up needed.[2] |
| SingleCare | $240-$280 | Free card; works with most pharmacies.[3] |
| RxSaver | $260-$300 | Similar to GoodRx; compare locally.[4] |
Prices fluctuate by pharmacy (e.g., Walmart often lowest); enter ZIP code on sites for real-time quotes.
What If Insurance Denies Coverage?
Appeal with prior authorization showing cardiovascular risk reduction data from REDUCE-IT trial. If denied, switch to generic icosapent ethyl (available since 2020) for $100-$200/month via coupons—same active ingredient, FDA-approved.[5] Patient assistance foundations like PAN Foundation may cover gaps for high-deductible plans.
Vascepa Patent Status and Generic Timeline
Patents on Vascepa expired in 2020 for the molecule, enabling generics from Hikma and others. Key formulation patents (e.g., purity claims) face challenges; some expire 2026-2031, but generics are already marketed without infringement issues per FDA approvals.[6] No major barriers to cheaper options now.
Sources
[1]: vascepa.com/savings
[2]: goodrx.com/vascepa
[3]: singlecare.com/prescription/vascepa
[4]: rxsaver.com/vascepa-coupon
[5]: FDA Generic Approvals
[6]: DrugPatentWatch.com - Vascepa Patents